IPO registrations (S-1, F-1) · Registrants

Tilray Brands, Inc.

SEC CIK
1731348 · filings on EDGAR ↗
Name on the registration
Tilray, Inc.
Former names
Tilray, Inc. (2018–2022)
Registration
Form S-1, first filed 2018-06-20, last 2018-07-17; 1 initial registration, 2 amendments
Outcome
Final prospectus filed 2018-07-19; declared effective 2018-07-18
Industry (SIC)
Medicinal Chemicals & Botanical Products 2833
Business address
445 PARK AVENUE, New York, NY 10022
EIN
82-4310622
Ticker
TLRY (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Tilray Brands, Inc. on the corporate pages

Offering terms

Proposed price range
$14.00–$16.00 per share (S-1/A filed 2018-07-17)
Final price
$17.00 per share, above the range (424B4 filed 2018-07-19, an initial public offering)
Shares sold
9,000,000
Gross proceeds
$153,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol TLRY
Lead underwriters
Cowen
Syndicate
Roth Capital Partners; Northland Securities; December 31 (2,016); As of December 31 (2,017); As of March 31 (2,018); Short-term investments – – (29,506); Accounts receivable, net 423 983 (1,077); Other receivables – (1,131)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 7

FiledFormWhat it isName as filedEDGAR
2018-06-20S-1S-1 (registration)Tilray, Inc.0001193125-18-197670 ↗
2018-07-09S-1/AS-1/A (amendment)Tilray, Inc.0001193125-18-214179 ↗
2018-07-17S-1/AS-1/A (amendment)Tilray, Inc.0001193125-18-219032 ↗
2018-07-18EFFECTEFFECT (declared effective)Tilray, Inc.9999999995-18-001824 ↗
2018-07-19424B4424B4 (final prospectus)Tilray, Inc.0001193125-18-221552 ↗
2018-07-19424B4424B4 (final prospectus)Tilray, Inc.0001193125-18-221569 ↗
2019-11-12EFFECTEFFECT (declared effective)Tilray, Inc.9999999995-19-002559 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2018-07-17S-1/Aregistration statement$14.00–$16.009,000,000-Nasdaq TLRY9primary document; range, shares headline, underwriting table 6, cover names 3document ↗
2018-07-19424B4final prospectus$17.009,000,000$153,000,000Nasdaq TLRY9primary document; price sentence, shares headline, proceeds table, underwriting table 6, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Auerbach MichaelDirector252018–2021
CASTANEDA MARKOfficerCFO, Secretary, Treasurer72018–2019
Dopp RebekahDirector132018–2021
Greenwood MaryscottDirector112018–2020
Kennedy BrendanDirector; Director,Officer; Director,Officer,TenPercentOwnerPresident and CEO452018–2022
Pastorius Edward Wood JROfficerChief Revenue Officer152018–2020
Privateer Holdings, Inc.TenPercentOwner12018
St.Clare ChristineDirector142018–2021
Pucher AndrewOfficerChief Corporate Dev Officer72019–2021
Levin Jon EdwardOfficerChief Operating Officer62020–2021
Kruteck Michael C.OfficerChief Financial Officer62020–2021
Dickson Kathryn POfficerPresident- Manitoba Harvest22020
Schroder SorenDirector32020–2021
FALTISCHEK DENISE MOfficerChief Strategy Officer212021–2026
Persofsky RenahDirector152021–2026
ROBB WALTER E IVDirector52021–2022
SIMON IRWIN DDirector,Officer; OfficerPresident and CEO; President & CEO242021–2026
Butts Jodi L.Director92021–2024
Herhalt Johann MichaelDirector122021–2026
Hopkinson David G.Director122021–2026
Looney Thomas P.Director122021–2026
Meiers James R.OfficerChief Operations Officer; Head of Canada82021–2022
Merton Carl AOfficerChief Financial Officer262021–2026
Clanachan David FDirector102021–2026
Gendel MitchellOfficerGlobal General Counsel182021–2026
Cohen Steven MichaelDirector52024–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2018-02-20Tilray, Inc.Other$56,136,343$50,367,888121

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationTilray Brands, Inc.NYState business registriesname and state
Business registrationTILRAY BRANDS, INC.NYState business registriesname and state
Business registrationTILRAY BRANDS, INC.NYState business registriesname and state
Plan sponsorTILRAY, INC.NYForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerTilray, Inc.WAForm D private offeringsCIK (EXACT)
Lobbying clientTILRAY BRANDS INC.NYFederal lobbying (LDA)name and state
Lobbying registrantTILRAY BRANDS INC.NYFederal lobbying (LDA)name and state
SEC filerTilray Brands, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerTilray Brands, Inc.NYTrademarks (USPTO)name and state
Form 5500 plan sponsorTILRAY, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Medicinal Chemicals & Botanical Products, NY first:

More with this interest.

In other datasets, the same topic (Health) in NY:

Interests: Medicinal Chemicals & Botanical Products · Health